China's power transition under the global 1.5 °C target: preliminary feasibility study and prospect.

Environ Sci Pollut Res Int

School of Economics and Management, North China Electric Power University, No 2, Beinong Road, Beijing, 102206, China.

Published: May 2020

Based on the 1.5 °C temperature control target of the Paris Agreement, the two scenarios in this paper which are 1.5 degree scenario (1.5DS) and 2 degree scenario (2DS) aim to analyze the CO emission space and power transition path constrains of the power sector in China. This paper then discusses the possible scenarios of 1.5DS and 2DS power planning schemes in 2050. The conclusions are as follows: (1) China's electricity consumption saturation period will occur during the period of 2030-2040; (2) Driven by technology learning, the levelized cost of electricity (LCOE) of wind power will have obvious competitive advantages in 2020 and so does solar power in 2030. However, due to the impact of additional grid connection costs of new energy power, economic advantages can only be obtained in the power market after at least 10 years; (3) The installed capacity of coal power in 1.5DS and 2DS will peak in 2020, and CO emissions will also peak in 2020, then it shows a trend of decreasing year by year. However, it should be noted that 1.5DS is with possibilities, but with enormous challenges as the same time; (4) Accelerating the green and low carbon transition of power sector must be gradually improving the power market and electricity price mechanism, providing a good transition environment for the power sector, developing emerging power technology, and promoting multi-energy complementary systems.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11356-020-08085-9DOI Listing

Publication Analysis

Top Keywords

power
12
power sector
12
power transition
8
degree scenario
8
15ds 2ds
8
power market
8
will peak
8
peak 2020
8
china's power
4
transition
4

Similar Publications

To compare the efficacy and safety of low-power holmium laser enucleation of the prostate (LP-HoLEP) with plasma kinetic resection of prostate (PKRP). Sixty-three patients treated with transurethral LP-HoLEP (observation group) and 68 patients treated with transurethral PKRP (control group) at Beijing Hospital of Traditional Chinese Medicine from November 2019 to November 2022 were retrospectively compared with regard to operation duration, intra-operative blood loss, prostate resection ratio, postoperative bladder irrigation time, postoperative indwelling urinary catheter time, postoperative urinary incontinence incidence, International Prostate Symptom Scale (IPSS), maximum urine flow rate (Qmax), and residual urine volume (RUV). In both groups, postoperative IPSS, Qmax, and RUV were significantly improved compared to preoperative values (P < 0.

View Article and Find Full Text PDF

Comparison of two strategies estimating surgically induced astigmatism in position prediction of toric IOLs in 2.2 mm cataract surgery.

Graefes Arch Clin Exp Ophthalmol

December 2024

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China.

Purpose: To compare the precision of the arithmetic mean of surgically induced astigmatism (M-SIA) and the centroid of surgically induced astigmatism (C-SIA) in estimating SIA when predicting the power and axis of toric IOLs under different circumstances.

Methods: 120 eyes of 99 patients undergoing toric IOL replacement in a simple cataract surgery were included in the retrospective study. The predicted position of toric IOL was calculated by Z Calc online calculator and Barrett Toric Calculator with M-SIA (0.

View Article and Find Full Text PDF

Magnetocaloric high-entropy alloys (HEAs) have recently garnered significant interest owing to their potential applications in magnetic refrigeration, offering a wide working temperature range and large refrigerant capacity. In this study, we thoroughly investigated the structural, magnetic, and magnetocaloric properties of equiatomic GdDyHoErTm HEAs. The as-cast alloy exhibits a single hexagonal phase, a randomly distributed grain orientation, and complex magnetism.

View Article and Find Full Text PDF

No FDA-approved medications for methamphetamine (MA) use disorder (MUD) are available. Suvorexant (SUVO), a dual orexin receptor antagonist that is FDA approved for insomnia treatment, reduces MA self-administration and MA-induced reinstatement responding in preclinical studies. SUVO may also reduce MA use by targeting substance use risk factors, including insomnia, stress, cue reactivity, and craving.

View Article and Find Full Text PDF

Genetic architecture of Multiple Myeloma and its prognostic implications - An updated review.

Malays J Pathol

December 2024

Universiti Sains Malaysia, School of Medical Sciences, Human Genome Centre, Health Campus, Kelantan, Malaysia.

Multiple myeloma (MM), a clonal B-cell neoplasia, is an incurable and heterogeneous disease where survival ranges from a few months to more than 10 years. The clinical heterogeneity of MM arises from multiple genomic events that result in tumour development and progression. Recurring genomic abnormalities including cytogenetic abnormalities, gene mutations and abnormal gene expression profiles in myeloma cells have a strong prognostic power.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!